Benicar Hct

   
Google
 
Web NewDrugInformation.com

Benicar Hct


Drug - Benicar Hct
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Hydrochlorothiazide; Olmesartan Medoxomil
Multiple ingredients are in alphabetical order.

Strength - 25MG;40MG
The potency of the active ingredient(s), Hydrochlorothiazide; Olmesartan Medoxomil. May repeat for multiple part products.

Applicant - SANKYO
The firm name holding legal responsibility for Benicar Hct. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 021532
The FDA assigned number to Benicar Hct. Format is nnnnnn.

Product Number - 005
The FDA assigned number to identify Benicar Hct. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jun 5, 2003
The date Benicar Hct was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Benicar Hct. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Benicar Hct is in. Format is RX, OTC, DISCN.

Applicant Full Name - Sankyo Pharma Inc
The full name of the firm holding legal responsibility for the new application of Benicar Hct.

Benicar Hct